scispace - formally typeset
S

Stéphane Laurent

Researcher at University of Paris

Publications -  428
Citations -  82831

Stéphane Laurent is an academic researcher from University of Paris. The author has contributed to research in topics: Blood pressure & Arterial stiffness. The author has an hindex of 83, co-authored 424 publications receiving 75440 citations. Previous affiliations of Stéphane Laurent include University of Lausanne & Paris Descartes University.

Papers
More filters
Journal ArticleDOI

Smooth Muscle Tone and Arterial Wall Viscosity An In Vivo/In Vitro Study

TL;DR: Results show that arterial wall viscosity (AWV) is strongly influenced by steady and pulsatile mechanical load but not by smooth muscle tone, both in vivo and in vitro.
Journal ArticleDOI

Arterial Stiffness Assessment by Shear Wave Elastography and Ultrafast Pulse Wave Imaging: Comparison with Reference Techniques in Normotensives and Hypertensives.

TL;DR: Shear wave speed in the carotid anterior appeared to be the best candidate to evaluate arterial stiffness from ultrafast imaging and increased with blood pressure throughout the cardiac cycle and did not differ between normotensive participants and patients with essential hypertension when compared at similar blood pressures.
Journal ArticleDOI

Pulse wave velocity is associated with early clinical outcome after ischemic stroke

TL;DR: In ischemic stroke, low aortic stiffness (CF-PWV) is associated with early favorable outcome, independently of other known prognostic factors.
Journal ArticleDOI

Differences in emotion processing in patients with essential and secondary hypertension.

TL;DR: The results are consistent with a contribution of an emotional or psychosomatic component in EH and may have practical implications for the nonpharmacological management of hypertension and demonstrate the utility of complementary measures of emotion processing in medically ill patients.
Journal ArticleDOI

Importance of arterial stiffness as cardiovascular risk factor for future development of new type of drugs.

TL;DR: To become a surrogate endpoint for drug development, there is a need to demonstrate that regression arterial stiffness is associated with improved outcome, and points to be improved are the homogenization and spreading of the technique of measurement, the establishment of a reference value database.